METHODS	Patients with negative hepatitis B surface antibody and antigen who had received at least three doses of recombinant hepatitis B vaccine without response ( antibody titre < 10 mIU/ml ) were randomized to placebo , 40 microg , or 80 microg of GM-CSF given with 40 microg recombinant hepatitis B vaccine i.m. at the same site .\